Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2004;89:83-85
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Archives of Disease in Childhood 2004;89:83-85
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health

ARCHIMEDES

Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia?

Report by

Dominik Müller1, Miriam Zimmering2, Charles Christoph Roehr3

Edited by Bob Phillips

1 Department of Pediatric Nephrology, Charité, Humboldt University, Berlin, Germany
2 Department of Pediatric Nephrology, Charité, Humboldt University, Berlin, Germany
3 Department of Neonatology, Charité Campus Mitte, Humboldt University, Berlin, Germany; christoph.roehr@charite.de

Keywords: nifedipine; hypoglycaemia

The first 150 words of the full text of this article appear below.

A 5 year old boy, suffering from hyperinsulinaemic hypoglycaemia since infancy and arterial hypertension secondary to polycystic kidney disease, was given nifedipine (0.3 mg/kg three times a day) to treat his high blood pressure. Normotension was restored and his blood sugar levels normalised. We wondered whether nifedipine could be used safely as long term treatment to counter hypoglycaemia in persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI)?

Structured clinical question

In a child with persistent hyperinsulinaemic hypoglycaemia of infancy [patient], can nifedipine [intervention] safely be given to treat hypoglycaemia [outcome]?

Search strategy and outcome

Search terms: "persistent hyperinsulinemic hypoglycaemia of infancy" and "hyperinsulinism" and "nifedipine" and "safety" and "calcium antagonist".

Cochrane Library (nifedipine or persistent hyperinsulinemic hypoglycaemia of infancy): no relevant study found. PubMed (limits: language English; age 0–18 years): one practice guideline,1 six case reports or patient series of PHHI treated with nifedipine,2–7 one report on the safety of calcium channel blockers in children.12 See table . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs